Clinical Trial Update: Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing switching from enoxaparin to rivaroxaban to prevent postoperative blood clots following total hip or total knee replacement; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Osteoarthritis
• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Arthritis, Osteoarthritis, Knee | Phase 3 | Status: COMPLETED | Results posted: 2012-02-27